Page last updated: 2024-08-25

almagate and Corneal Angiogenesis

almagate has been researched along with Corneal Angiogenesis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Andrade, N; Araújo E Silva, PM; Crispim Ribeiro, J; de Moraes, MO; Fechine, FV; Savio, D1
Bock, F; Bucher, F; Cursiefen, C; Hos, D; Lipp, M; Onderka, J; Parthasarathy, A1
Bachmann, B; Bock, F; Cursiefen, C; Hos, D; König, Y; Parthasarathy, A; Regenfuss, B1
Caglar, Y; Degirmenci, E; Ozdemir, O; Sener, E; Yildiz, DK; Yilmaz, B; Yuksel, N1
Adamis, AP; Bradley, J; Calias, P; Cook, G; Dowie, T; Ganley, M; Ju, M; Lange, N; Mailhos, C; Robinson, GS; Shima, DT1
Dadgostar, H; Waheed, N1

Reviews

2 review(s) available for almagate and Corneal Angiogenesis

ArticleYear
[Topical inhibition of angiogenesis at the cornea. Safety and efficacy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2009, Volume: 106, Issue:5

    Topics: Administration, Topical; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Corneal Neovascularization; Humans; Ophthalmic Solutions; Ranibizumab; Treatment Outcome

2009
The evolving role of vascular endothelial growth factor inhibitors in the treatment of neovascular age-related macular degeneration.
    Eye (London, England), 2008, Volume: 22, Issue:6

    Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Clinical Trials, Phase III as Topic; Corneal Neovascularization; Dose-Response Relationship, Drug; Female; Humans; Macular Degeneration; Male; Practice Guidelines as Topic; Ranibizumab; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A

2008

Other Studies

4 other study(ies) available for almagate and Corneal Angiogenesis

ArticleYear
Effect of Topical Instillation of Pegaptanib Sodium Upon Inflammatory Corneal Neovascularization in Rabbits.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2021, Volume: 37, Issue:5

    Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Aptamers, Nucleotide; Caustics; Cornea; Corneal Injuries; Corneal Neovascularization; Disease Models, Animal; Inflammation; Instillation, Drug; Male; Neovascularization, Pathologic; Prednisolone; Rabbits; Sodium Hydroxide; Treatment Outcome; Vascular Endothelial Growth Factor A

2021
Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2014, Volume: 252, Issue:6

    Topics: Administration, Topical; Animals; Aptamers, Nucleotide; Cell Proliferation; Corneal Neovascularization; Disease Models, Animal; Endothelial Cells; Female; Fluorescent Antibody Technique, Indirect; Glycoproteins; Lymphangiogenesis; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Ophthalmic Solutions; Platelet Endothelial Cell Adhesion Molecule-1; Protein Isoforms; Vascular Endothelial Growth Factor A

2014
The impact of subconjuctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model.
    Current eye research, 2011, Volume: 36, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctiva; Corneal Neovascularization; Disease Models, Animal; Epidermal Growth Factor; Follow-Up Studies; Injections; Male; Ranibizumab; Rats; Rats, Wistar; Receptor, ErbB-2; Trastuzumab; Treatment Outcome; Vascular Endothelial Growth Factor A

2011
Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:2

    Topics: Animals; Aptamers, Nucleotide; Choroidal Neovascularization; Chromatography, High Pressure Liquid; Cornea; Corneal Neovascularization; Disease Models, Animal; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Photochemotherapy; Photosensitizing Agents; Porphyrins; RNA, Messenger; Thromboplastin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Verteporfin

2008